Compagnie Lombard Odier SCmA’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Hold
9,000
– – ﹤0.01% 259
2026
Q1
$172K Hold
9,000
– – ﹤0.01% 262
2025
Q4
$218K Hold
9,000
– – ﹤0.01% 245
2025
Q3
$230K Hold
9,000
– – ﹤0.01% 243
2025
Q2
$194K Hold
9,000
– – ﹤0.01% 239
2025
Q1
$206K Hold
9,000
– – ﹤0.01% 256
2024
Q4
$234K Hold
9,000
– – ﹤0.01% 230
2024
Q3
$225K Hold
9,000
– – ﹤0.01% 234
2024
Q2
$193K Hold
9,000
– – ﹤0.01% 247
2024
Q1
$167K Hold
9,000
– – ﹤0.01% 277
2023
Q4
$146K Hold
9,000
– – ﹤0.01% 319
2023
Q3
$124K Hold
9,000
– – ﹤0.01% 331
2023
Q2
$199K Hold
9,000
– – 0.01% 265
2023
Q1
$196K Hold
9,000
– – ﹤0.01% 293
2022
Q4
$164K Hold
9,000
– – ﹤0.01% 317
2022
Q3
$205K Hold
9,000
– – 0.01% 296
2022
Q2
$124K Hold
9,000
– – ﹤0.01% 358
2022
Q1
$205K Hold
9,000
– – ﹤0.01% 306
2021
Q4
$335K Hold
9,000
– – 0.01% 291
2021
Q3
$381K Hold
9,000
– – 0.01% 276
2021
Q2
$401K Hold
9,000
– – 0.01% 258
2021
Q1
$324K Hold
9,000
– – 0.01% 333
2020
Q4
$359K Hold
9,000
– – 0.01% 264
2020
Q3
$260K Hold
9,000
– – 0.01% 253
2020
Q2
$147K Hold
9,000
– – ﹤0.01% 297
2020
Q1
$85K Buy
+9,000
New +$124K ﹤0.01% 311

Other funds holding BLFS

Compagnie Lombard Odier SCmA's BLFS Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA held its BioLife Solutions (BLFS) position steady in Q2 2026 at 9,000 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Compagnie Lombard Odier SCmA first reported a position in BLFS in Q1 2020 and has held it in 26 quarters since. The position peaked at $401K in Q2 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 9,000 shares of BioLife Solutions worth $254K as of Q2 2026.
  • Compagnie Lombard Odier SCmA left its BioLife Solutions share count unchanged in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #259 holding.
  • Compagnie Lombard Odier SCmA first reported a position in BioLife Solutions in Q1 2020 and has held it in 26 quarters since.
  • Compagnie Lombard Odier SCmA's BioLife Solutions position peaked at $401K in Q2 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.